The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom, P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N., et al. (2007) · Nature · doi:10.1038/nature05571 · Cited by 1,775
Deficient T Cell Fate Specification in Mice with an Induced Inactivation of Notch1
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., MacDonald, H. R., & Aguet, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80054-0 · Cited by 1,405
Self-citationEphrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
Wang, Y., Nakayama, M., Pitulescu, M. E., Schmidt, T. S., Bochenek, M. L., Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lüthi, U., et al. (2010) · Nature · doi:10.1038/nature09002 · Cited by 1,271
Self-citationThe Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis
Benedito, R., Roca, C., Sörensen, I., Adams, S., Gossler, A., Fruttiger, M., & Adams, R. H. (2009) · Cell · doi:10.1016/j.cell.2009.03.025 · Cited by 1,107
Self-citationBlockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis
Noguera-Troise, I., Daly, C., Papadopoulos, N. J., Coetzee, S., Boland, P., Gale, N. W., Chieh Lin, H., Yancopoulos, G. D., & Thurston, G. (2006) · Nature · doi:10.1038/nature05355 · Cited by 1,032
Angiogenesis: A Team Effort Coordinated by Notch
Phng, L.-K., & Gerhardt, H. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.015 · Cited by 832
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
Tammela, T., Zarkada, G., Wallgard, E., Murtomäki, A., Suchting, S., Wirzenius, M., Waltari, M., Hellström, M., Schomber, T., Peltonen, R., et al. (2008) · Nature · doi:10.1038/nature07083 · Cited by 813
Self-citationSuchting, S., Freitas, C., le Noble, F., Benedito, R., Bréant, C., Duarte, A., & Eichmann, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611177104 · Cited by 811
Self-citationDelta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting
Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., & Wiegand, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611206104 · Cited by 774
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Lohela, M., Bry, M., Tammela, T., & Alitalo, K. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.012 · Cited by 738
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Self-citationNotch signalling limits angiogenic cell behaviour in developing zebrafish arteries
Siekmann, A. F., & Lawson, N. D. (2007) · Nature · doi:10.1038/nature05577 · Cited by 687
Han, H., Tanigaki, K., Yamamoto, N., Kuroda, K., Yoshimoto, M., Nakahata, T., Ikuta, K., & Honjo, T. (2002) · International Immunology · doi:10.1093/intimm/dxf030 · Cited by 587
Dosage‐sensitive requirement for mouse Dll4 in artery development
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Bekman, E., Costa, L., Henrique, D., & Rossant, J. (2004) · Genes & Development · doi:10.1101/gad.1239004 · Cited by 563
Self-citationKoch, U., Fiorini, E., Benedito, R., Besseyrias, V., Schuster-Gossler, K., Pierres, M., Manley, N. R., Duarte, A., MacDonald, H. R., & Radtke, F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080829 · Cited by 464
Self-citationLiang, W.-C., Wu, X., Peale, F. V., Lee, C. V., Meng, Y. G., Gutierrez, J., Fu, L., Malik, A. K., Gerber, H.-P., Ferrara, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508199200 · Cited by 346
Efficient, inducible Cre‐recombinase activation in vascular endothelium
Claxton, S., Kostourou, V., Jadeja, S., Chambon, P., Hodivala‐Dilke, K., & Fruttiger, M. (2008) · genesis · doi:10.1002/dvg.20367 · Cited by 327
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling
Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., Zheng, W., Franco, C. A., Murtomäki, A., Aranda, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2331 · Cited by 321
Biomarkers to predict the clinical efficacy of bevacizumab in cancer
Jubb, A. M., & Harris, A. L. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70232-1 · Cited by 295
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling
Haigh, J. J., Morelli, P. I., Gerhardt, H., Haigh, K., Tsien, J., Damert, A., Miquerol, L., Muhlner, U., Klein, R., Ferrara, N., et al. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00356-7 · Cited by 272
Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries
Hogan, B. M., Herpers, R., Witte, M., Heloterä, H., Alitalo, K., Duckers, H. J., & Schulte-Merker, S. (2009) · Development · doi:10.1242/dev.039990 · Cited by 253
Pytowski, B., Goldman, J., Persaud, K., Wu, Y., Witte, L., Hicklin, D. J., Skobe, M., Boardman, K. C., & Swartz, M. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji003 · Cited by 248
Self-citationSainson, R. C. A., Aoto, J., Nakatsu, M. N., Holderfield, M., Conn, E., Koller, E., & Hughes, C. C. W. (2005) · The FASEB Journal · doi:10.1096/fj.04-3172fje · Cited by 227
Harrington, L. S., Sainson, R. C. A., Williams, C. K., Taylor, J. M., Shi, W., Li, J.-L., & Harris, A. L. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.06.006 · Cited by 215
Taylor, K. L., Henderson, A. M., & Hughes, C. C. W. (2002) · Microvascular Research · doi:10.1006/mvre.2002.2443 · Cited by 199
VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis
Thurston, G., & Kitajewski, J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604484 · Cited by 182
Modulation of VEGF signalling output by the Notch pathway
Siekmann, A. F., Covassin, L., & Lawson, N. D. (2008) · BioEssays · doi:10.1002/bies.20736 · Cited by 172
Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
Lux, A., Llacer, H., Heussen, F. M. A., & Joussen, A. M. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.113902 · Cited by 168
Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo
Stenzel, D., Franco, C. A., Estrach, S., Mettouchi, A., Sauvaget, D., Rosewell, I. R., Schertel, A., Armer, H. E. J., Domogatskaya, A., Rodin, S., et al. (2011) · EMBO Reports · doi:10.1038/embor.2011.194 · Cited by 160
Zhang, L., Zhou, F., Han, W., Shen, B., Luo, J., Shibuya, M., & He, Y. (2010) · Cell Research · doi:10.1038/cr.2010.116 · Cited by 152
Manley, P. W., Bold, G., Brüggen, J., Fendrich, G., Furet, P., Mestan, J., Schnell, C., Stolz, B., Meyer, T., Meyhack, B., et al. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.11.010 · Cited by 136
Laminin-Binding Integrins Induce Dll4 Expression and Notch Signaling in Endothelial Cells
Estrach, S., Cailleteau, L., Franco, C., Gerhardt, H., Stefani, C., Lemichez, E., Gagnoux-palacios, L., Meneguzzi, G., & Mettouchi, A. (2011) · Circulation Research · doi:10.1161/circresaha.111.240622 · Cited by 120
Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors
Manley, P. W., Furet, P., Bold, G., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020899q · Cited by 103
Galvagni, F., Pennacchini, S., Salameh, A., Rocchigiani, M., Neri, F., Orlandini, M., Petraglia, F., Gotta, S., Sardone, G. L., Matteucci, G., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206326 · Cited by 87
Cited by
Mechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498
Targeting VEGF/VEGFR to modulate antitumor immunity
Yang, J., Yan, J., & Liu, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00978 · Cited by 646
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Welti, J., Loges, S., Dimmeler, S., & Carmeliet, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70212 · Cited by 591
VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis
Abhinand, C. S., Raju, R., Soumya, S. J., Arya, P. S., & Sudhakaran, P. R. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0352-8 · Cited by 502
Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role
Wang, X., Bove, A. M., Simone, G., & Ma, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599281 · Cited by 442
Metadata
- Authors
- Benedito, R., Rocha, S. F., Woeste, M., Zamykal, M., Radtke, F., Casanovas, O., Duarte, A., Pytowski, B., & Adams, R. H.
- Venue
- Nature
- Published
- 2012-03-18
- Volume
- 484
- Issue
- 7392
- Pages
- 110-114
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2095002343
- Cited by
- 362
- References
- 35
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.